- Home
- CVAC vs BZH Comparison
CVAC vs BZH Comparison
Compare CVAC & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- BZH
- Stock Information
- Founded
- CVAC 2000
- BZH 1985
- Country
- CVAC Germany
- BZH United States
- Employees
- CVAC N/A
- BZH N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- BZH Homebuilding
- Sector
- CVAC Health Care
- BZH Consumer Discretionary
- Exchange
- CVAC Nasdaq
- BZH Nasdaq
- Market Cap
- CVAC 812.1M
- BZH 796.6M
- IPO Year
- CVAC 2020
- BZH 1994
- Fundamental
- Price
- CVAC $4.10
- BZH $28.24
- Analyst Decision
- CVAC Hold
- BZH Strong Buy
- Analyst Count
- CVAC 3
- BZH 3
- Target Price
- CVAC $10.00
- BZH $39.67
- AVG Volume (30 Days)
- CVAC 1.2M
- BZH 285.9K
- Earning Date
- CVAC 11-12-2024
- BZH 01-30-2025
- Dividend Yield
- CVAC N/A
- BZH N/A
- EPS Growth
- CVAC N/A
- BZH N/A
- EPS
- CVAC N/A
- BZH 4.53
- Revenue
- CVAC $70,565,734.00
- BZH $2,330,197,000.00
- Revenue This Year
- CVAC $742.57
- BZH $20.29
- Revenue Next Year
- CVAC N/A
- BZH $14.20
- P/E Ratio
- CVAC N/A
- BZH $6.24
- Revenue Growth
- CVAC 75.11
- BZH 5.59
- 52 Week Low
- CVAC $2.22
- BZH $25.39
- 52 Week High
- CVAC $5.28
- BZH $38.22
- Technical
- Relative Strength Index (RSI)
- CVAC 62.06
- BZH 47.87
- Support Level
- CVAC $3.89
- BZH $27.88
- Resistance Level
- CVAC $4.32
- BZH $28.89
- Average True Range (ATR)
- CVAC 0.33
- BZH 0.85
- MACD
- CVAC 0.03
- BZH 0.37
- Stochastic Oscillator
- CVAC 54.27
- BZH 75.90
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.